Jenna Sarvaideo DO

Research Areas of Interest
HypogonadismResearch Experience
Transgender PersonsClinical Expertise
AndropauseHealth Services for Transgender PersonsHypogonadismKallmann SyndromeKlinefelter SyndromeMenopausePolycystic Ovary SyndromeTurner SyndromePublications (16)
Hypercalcemia due to CYP24A1 variants in five unrelated patients: diagnostic and clinical considerations. (Sarvaideo JL, Colón-Franco JM, Kumar R, Shaker JL) JBMR Plus 2025 Sep;9(9):ziaf102 PMID: 40765620 PMCID: PMC12319318 SCOPUS ID: 2-s2.0-105012510883 08/06/2025 Your patient’s menopause symptoms could be a warning sign for something worse (Meghan McCallum, Barbara Bekiesz, Jenna Sarvaideo) MDLinx 03/18/2025 In Reply to Gad Et Al "Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay". (Nerenz RD, Javorsky BR, Sarvaideo J, Straseski JA, Earll E) Clin Endocrinol (Oxf) 2025 May;102(5):557-558 PMID: 39777755 SCOPUS ID: 2-s2.0-85214406364 01/09/2025 Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. (Rothman MS, Hamnvik OR, Davidge-Pitts C, Safer JD, Ariel D, Tangpricha V, Abramowitz J, Soe K, Sarvaideo J, Kelley C, Irwig MS, Iwamoto SJ) Transgend Health 2024 Dec;9(6):463-465 PMID: 39735380 PMCID: PMC11669617 SCOPUS ID: 2-s2.0-85196491881 12/30/2024 3 CitationsMenopause Facts and Myths (Afsari, Seema; Lynd, Francesca; Sarvaideo, Jenna; Lippman, Alyson) MKE Lifestyle 08/01/2024 Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay. (Earll E, Javorsky BR, Sarvaideo J, Straseski JA, Nerenz RD) J Endocr Soc 2024 Apr 06;8(6):bvae069 PMID: 38698869 PMCID: PMC11065352 SCOPUS ID: 2-s2.0-85192495436 05/03/2024 4 CitationsTwo Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation. (Wolf Pulsiano SL, Sarvaideo JL) AACE Clin Case Rep 2023;9(6):201-204 PMID: 38045793 PMCID: PMC10690401 SCOPUS ID: 2-s2.0-85175345188 12/04/2023 2 CitationsTwo Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation (Wolf Pulsiano SL, Sarvaideo JL) AACE Clinical Case Reports 1 November 2023;9(6):201-204 SCOPUS ID: 2-s2.0-85175345188 11/01/2023 2 CitationsEstrogen and the Vascular Endothelium: The Unanswered Questions. (SenthilKumar G, Katunaric B, Bordas-Murphy H, Sarvaideo J, Freed JK) Endocrinology 2023 Apr 17;164(6) PMID: 37207450 PMCID: PMC10230790 SCOPUS ID: 2-s2.0-85163898622 05/20/2023 38 CitationsThe Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone. (Hayes H, Russell R, Haugen A, Nagavally S, Sarvaideo J) J Endocr Soc 2022 Oct 11;6(11):bvac133 PMID: 36267595 PMCID: PMC9562816 SCOPUS ID: 2-s2.0-85144549183 10/22/2022 7 CitationsMore Studies Are Needed to Establish the Safety and Efficacy of Sublingual Estradiol in Transgender Women. (Sarvaideo J, Doll E, Tangpricha V) Endocr Pract 2022 Mar;28(3):353-354 PMID: 35074501 SCOPUS ID: 2-s2.0-85125482531 01/26/2022 1 CitationPharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. (Doll E, Gunsolus I, Thorgerson A, Tangpricha V, Lamberton N, Sarvaideo JL) Endocr Pract 2022 Mar;28(3):237-242 PMID: 34781041 SCOPUS ID: 2-s2.0-85121347509 11/16/2021 14 CitationsPolycystic Ovary Syndrome (Nasseh A, Sarvaideo J) Sex and Gender Based Women S Health A Practical Guide for Primary Care 1 January 2021:83-97 SCOPUS ID: 2-s2.0-105011788774 01/01/2021 1 CitationHYPERCALCEMIC CRISIS IN A PATIENT WITH A HUGE MEDIASTINAL ATYPICAL PARATHYROID ADENOMA (Jenna L. Sarvaideo, DO1; Jennifer Clark, MD2; Kathryn E. Coan, MD3; Oleksandr Kravtsov, MD4; Amanda Jacquart, MS, CGC5; Paul Knudson, MD1; Diana Maas, MD1; Robert D. Blank, MD, PhD1; Tracy S. Wang, MD3; Joseph L. Shaker, MD1) AACE Clinical Case Reports https://doi.org/10.4158/EP171959.CR 05/01/2018 Hypercalcemic Crisis in A Patient with A Huge Mediastinal Atypical Parathyroid Adenoma (Sarvaideo JL, Clark J, Coan KE, Kravtsov O, Jacquart A, Knudson P, Maas D, Blank RD, Wang TS, Shaker JL) AACE Clinical Case Reports 1 May 2018;4(3):224-227 SCOPUS ID: 2-s2.0-85124183534 05/01/2018 Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis. (Hillard CJ, Beatka M, Sarvaideo J) Compr Physiol 2016 Dec 06;7(1):1-15 PMID: 28134998 PMCID: PMC5871916 SCOPUS ID: 2-s2.0-85020983619 01/31/2017 92 Citations Last update: 11/20/2025